We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,026

President’s Proposed Budget Increases Healthcare Fraud Enforcement Funding
  • McGuireWoods LLP
  • USA
  • March 20 2017

Much of the discussion surrounding President Trump’s 2018 budget blueprint has focused on cuts, but one proposed budget increase shows the new


Highlights from the 2016 OIG Work Plan
  • McGuireWoods LLP
  • USA
  • December 9 2015

The Office of Inspector General (OIG) of the Department of Health and Human Services (HHS) has released its Work Plan for Fiscal Year 2016. The


Leading Private Equity Firms That Invest in Healthcare (Part I)
  • McGuireWoods LLP
  • USA
  • February 17 2016

In the past decade, the list of investors that have put their capital to work in the healthcare and life sciences industries has grown dramatically


Optum-SCA Merger Could Signal Renewed Payer Interest in Providers
  • McGuireWoods LLP
  • USA
  • March 10 2017

In January, UnitedHealth Group’s health services arm Optum announced it would acquire Surgical Care Affiliates (SCA), one of the nation’s largest and


Lessons Gleaned From Recent HIPAA Settlements: An Ounce of Prevention is Worth a Pound of Cure: How Recent OCR Enforcement Impacts Your Transaction Diligence
  • McGuireWoods LLP
  • USA
  • February 23 2017

HIPAA enforcement has been on the rise during the last several years, and the dollar impact of those settlements has continued to grow significantly


Washington Healthcare Update - March 20, 2017
  • McGuireWoods LLP
  • USA
  • March 20 2017

By a narrow 19-17 vote, the House Budget Committee sent the bill to repeal and replace the Affordable Care Act (ACA) through the committee March 16


Washington Healthcare Update - March 6, 2017
  • McGuireWoods LLP
  • USA
  • March 6 2017

On March 2, the House Energy and Commerce Committee reviewed the “Lower Drug Costs through Competition Act,” a bill aimed at incentivizing generic


Leading Private Equity Firms That Invest in Healthcare (Part II)
  • McGuireWoods LLP
  • USA
  • May 17 2016

Private equity interest in the healthcare and life sciences sectors has continued to grow at a rapid pace during recent years. Many investors are


The Rising Importance of Data Privacy and Security Practices for Healthcare Entities Facing Intensified Challenges
  • McGuireWoods LLP
  • USA
  • February 28 2017

For those in the healthcare industry, the privacy and security of information is vital to operations, but the importance and value of health


Washington Healthcare Update - May 02, 2016
  • McGuireWoods LLP
  • USA
  • May 2 2016

On April 27, the House Judiciary Committee approved opioid legislation that will be rolled into a larger measure to be the chamber’s alternative to